Status:

UNKNOWN

Study of Renal Blood Flow During Human Endotoxemia

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Healthy

Type 2 Diabetes

Eligibility:

MALE

25-80 years

Phase:

NA

Brief Summary

The purpose of the present protocol is to study whether endotoxemia will affect the renal blood flow in type 2 diabetics and healthy volunteers.

Detailed Description

Many septic patients develop acute renal failure and the risk is higher in patients with diabetes. The pathogenetic mechanisms behind the development of acute renal failure in connection with sepsis i...

Eligibility Criteria

Inclusion

  • Healthy
  • Type 2 diabetes

Exclusion

  • Renal failure
  • Heart failure
  • Lung disease

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

End Date :

December 1 2007

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT00413465

Start Date

November 1 2006

End Date

December 1 2007

Last Update

December 19 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Intensiv Care Unit, Rigshospitalet,

Copenhagen, Denmark, 2100